AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cannabix Technologies Inc.

$0.3 -$0.14 (-31.32%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.31
Day Range
$0.3$0.3
Year Range
$0.26$0.68
Market Cap
36.41M
AVG Volume
71.58K
Trailing/Forward PE
-8.54/-
PEG ratio
0.4
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD) · TTM
050K100K150K200K24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
BLOZF Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
26 Q436
26 Q3158.54K
26 Q2123.02K
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
Net Income (CAD) · TTM
-8M-6M-4M-2M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
BLOZF Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
26 Q4-5.76M
26 Q3-6.26M
26 Q2-6.33M
26 Q1-5.9M
25 Q4-4.69M
25 Q3-3.32M
25 Q2-3.33M
25 Q1-3.8M
24 Q4-3.13M
24 Q3-2.29M
Operating Income (CAD) · TTM
-8M-6M-4M-2M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
BLOZF Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
26 Q4-5.92M
26 Q3-6.19M
26 Q2-6.22M
26 Q1-5.81M
25 Q4-4.62M
25 Q3-3.12M
25 Q2-3.18M
25 Q1-3.63M
24 Q4-2.96M
24 Q3-2.28M
EBITDA (CAD) · TTM
-8M-6M-4M-2M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
BLOZF EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
26 Q4-5.59M
26 Q3-6.1M
26 Q2-6.15M
26 Q1-5.72M
25 Q4-4.5M
25 Q3-2.97M
25 Q2-2.99M
25 Q1-3.53M
24 Q4-2.86M
24 Q3-1.97M
Cash Flows (CAD) · TTM
-3M-2M-1M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
BLOZF Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
26 Q4-1.74M
26 Q3-1.88M
26 Q2-2.05M
26 Q1-1.95M
25 Q4-1.86M
25 Q3-2.05M
25 Q2-2.05M
25 Q1-2.14M
24 Q4-2.1M
24 Q3-1.76M
EPS (CAD) · TTM
-0.06-0.04-0.02024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
BLOZF EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
26 Q4-0.05
26 Q3-0.05
26 Q2-0.05
26 Q1-0.05
25 Q4-0.04
25 Q3-0.03
25 Q2-0.03
25 Q1-0.03
24 Q4-0.03
24 Q3-0.02
Expenses (CAD) · TTM
02M4M6MR&DSG&ACapex24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
BLOZF Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
26 Q45.61M
26 Q35.85M
26 Q25.94M
26 Q15.5M
25 Q44.33M
25 Q33.02M
25 Q23.09M
25 Q13.58M
24 Q42.92M
24 Q32.02M
Shares Outstanding (CAD) · TTM
-2M-1.5M-1M-500K0Buybacks (Repurchases)Stock-Based Compensation24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
BLOZF Shares Outstanding (CAD) · TTM by quarter
PeriodShares Outstanding (CAD) · TTM
26 Q4-724.79K
26 Q3-1.65M
26 Q2-1.65M
26 Q1-1.26M
25 Q4-1.26M
25 Q3-347.25K
25 Q2-347.25K
25 Q1-802.17K
24 Q4-868.47K
24 Q3-384.37K
Free Cash Flow Yield
-6%-5%-4%-3%-2%med -2.94%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BLOZF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-3.5%
Sep 26-3.06%
Aug 26-2.93%
Aug 26-2.9%
Aug 26-2.82%
Aug 26-2.58%
Jul 26-2.84%
Jul 26-2.79%
Jul 26-2.81%
Jul 26-2.56%
Jul 26-2.81%
Jun 26-2.8%
Jun 26-2.54%
Jun 26-2.59%
Jun 26-2.44%
May 26-2.37%
May 26-2.39%
May 26-2.19%
May 26-2.16%
May 26-2.18%
Apr 26-2.25%
Apr 26-2.28%
Apr 26-2.2%
Apr 26-2.31%
Mar 26-2.18%
Mar 26-2.34%
Mar 26-3.31%
Mar 26-3.32%
Feb 26-3.02%
Feb 26-3.02%
Feb 26-3.13%
Feb 26-2.91%
Jan 26-2.85%
Jan 26-2.69%
Jan 26-2.61%
Jan 26-2.65%
Jan 26-2.78%
Dec 25-2.84%
Dec 25-2.91%
Dec 25-3.03%
Dec 25-3.24%
Nov 25-3.17%
Nov 25-2.98%
Nov 25-2.94%
Nov 25-2.91%
Oct 25-3.17%
Oct 25-3.02%
Oct 25-3.06%
Oct 25-2.97%
Oct 25-2.67%
Sep 25-2.99%
Sep 25-2.9%
Sep 25-2.89%
Sep 25-2.82%
Aug 25-2.8%
Aug 25-2.76%
Aug 25-2.8%
Aug 25-2.67%
Aug 25-2.78%
Jul 25-2.95%
Jul 25-2.85%
Jul 25-3.11%
Jul 25-2.84%
Jun 25-2.86%
Jun 25-2.85%
Jun 25-2.87%
Jun 25-2.8%
May 25-3.01%
May 25-3.03%
May 25-2.92%
May 25-3.12%
May 25-3.15%
Apr 25-3.14%
Apr 25-2.83%
Apr 25-2.95%
Apr 25-2.99%
Mar 25-3.43%
Mar 25-3.22%
Mar 25-3.27%
Mar 25-4.06%
Feb 25-4.11%
Feb 25-3.5%
Feb 25-3.7%
Feb 25-3.73%
Jan 25-3.16%
Jan 25-3.76%
Jan 25-4.69%
Jan 25-5.24%
Jan 25-5.57%
Dec 24-5.51%
Dec 24-5.56%
Dec 24-5.42%
Dec 24-4.72%
Nov 24-4.81%
Nov 24-5.02%
Nov 24-5.14%
Nov 24-4.26%
Nov 24-4.2%
Oct 24-4.07%
Oct 24-4.23%
Price to Sales
0500000100000015000002000000med 550.16Feb 26Mar 26Apr 26May 26Jul 26Aug 26Sep 26
BLOZF Price to Sales by quarter
PeriodPrice to Sales
Sep 261379484.29
Sep 261576914.82
Aug 261644261.7
Aug 261660196.85
Aug 261707778.63
Aug 261867796.68
Jul 261699574.56
Jul 26424.54
Jul 26421.87
Jul 26461.64
Jul 26421.48
Jun 26422.55
Jun 26466.59
Jun 26456.96
Jun 26485.19
May 26499.9
May 26495.95
May 26541.48
May 26548.19
May 26543.66
Apr 26739.69
Apr 26731.23
Apr 26758.01
Apr 26719.12
Mar 26763.42
Mar 26710.52
Mar 26502.99
Mar 26501.89
Feb 26550.16
Feb 26551.73
Feb 26532.31
Feb 26571.78
Jan 26582.91
Price to Book
0204060med 26.13Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BLOZF Price to Book by quarter
PeriodPrice to Book
Sep 2627.88
Sep 2631.87
Aug 2633.23
Aug 2633.55
Aug 2634.51
Aug 2637.75
Jul 2634.35
Jul 2642.82
Jul 2642.55
Jul 2646.56
Jul 2642.51
Jun 2642.62
Jun 2647.06
Jun 2646.09
Jun 2648.94
May 2650.42
May 2650.02
May 2654.61
May 2655.29
May 2654.83
Apr 2648.69
Apr 2648.13
Apr 2649.89
Apr 2647.33
Mar 2650.25
Mar 2646.77
Mar 2633.11
Mar 2633.04
Feb 2636.21
Feb 2636.32
Feb 2635.04
Feb 2637.64
Jan 2638.37
Jan 2631.78
Jan 2632.79
Jan 2632.27
Jan 2630.8
Dec 2530.07
Dec 2529.42
Dec 2528.22
Dec 2526.37
Nov 2526.99
Nov 2528.7
Nov 2529.09
Nov 2529.37
Oct 2526.96
Oct 2524.1
Oct 2523.86
Oct 2524.58
Oct 2527.33
Sep 2524.42
Sep 2525.12
Sep 2525.24
Sep 2525.81
Aug 2526.05
Aug 2526.39
Aug 2526.01
Aug 2527.27
Aug 2526.21
Jul 2522.81
Jul 2523.62
Jul 2521.64
Jul 2523.65
Jun 2523.48
Jun 2523.58
Jun 2523.44
Jun 2524.02
May 2522.32
May 2522.16
May 2523.06
May 2521.56
May 2521.37
Apr 2518.79
Apr 2520.87
Apr 2520
Apr 2519.77
Mar 2517.2
Mar 2518.3
Mar 2518.07
Mar 2514.53
Feb 2514.35
Feb 2516.86
Feb 2515.95
Feb 2515.84
Jan 2518.69
Jan 2514.44
Jan 2511.58
Jan 2510.38
Jan 259.75
Dec 249.86
Dec 249.77
Dec 2410.02
Dec 2411.52
Nov 2411.29
Nov 2410.83
Nov 2410.58
Nov 2412.76
Nov 2412.93
Oct 2411.57
Oct 2411.15
Cannabix Technologies Inc.
BLOZF
Stockpicker

Video analysis: BLOZF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BLOZF

Cannabix Technologies Deploys BreathLogix Alcohol Monitoring System with Lake County Community Corrections in Indiana's Second-Most Populous County

globenewswire.com · 10 Sep 2026

Cannabix Technologies Deploys BreathLogix Alcohol Monitoring System with Lake County Community Corrections in Indiana's Second-Most Populous County

VANCOUVER, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana and alcohol breath testing technologies, is pleased to announce the deployment of its BreathLogix alcohol monitoring solution with the Lake County Community Corrections Program in Indiana. Lake County is Indiana's second-most populous county, serving residents in the greater Chicago metropolitan region.

Cannabix Technologies Deploys BreathLogix Alcohol System at Montana's Big Horn County Probation and Pre-Trial Services Department Under State's 24/7 Sobriety Program

globenewswire.com · 20 Aug 2026

Cannabix Technologies Deploys BreathLogix Alcohol System at Montana's Big Horn County Probation and Pre-Trial Services Department Under State's 24/7 Sobriety Program

VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices, is pleased to announce the deployment of its BreathLogix alcohol screening solution with the Big Horn County Misdemeanor Probation and Pre-trial Services in Montana. The BreathLogix system will be located at the county detention center and overseen by the misdemeanor probation and pre-trial staff. The technology will support participant monitoring under Montana's 24/7 Sobriety Program and assist courts with compliance monitoring both within and beyond county jurisdictions. The deployment is being facilitated by AlcoPro, Inc., an authorized reseller.

Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference

globenewswire.com · 4 Aug 2026

Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference

VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”), a developer of marijuana and alcohol breath testing technologies for workplace and public safety is pleased to announce that its Marijuana Breath Test ("MBT") technology has been invited for presentation at the Association of Boxing Commissions and Combative Sports ("ABC") 38th Annual Conference, to be held at the Caribe Royale Resort in Orlando, Florida in August. The conference is recognized as one of the leading gatherings of combat sports regulators, athletic commissioners, medical professionals, referees, judges, inspectors, and industry stakeholders involved in professional boxing, mixed martial arts (MMA) and other combative sports.

Cannabix Technologies Annual General Meeting Results

globenewswire.com · 31 Jul 2026

Cannabix Technologies Annual General Meeting Results

VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) announces the results of its annual general meeting of common shareholders held on July 27, 2026 in Vancouver. Resolutions passed at the meeting included the appointment of SHIM and Associates LLP as auditors for the ensuing year, and the election of five directors: Dr. Raj Attariwala, Dr. Phillip Olla, Ravinder Mlait, Bryan Loree, and William Corl.

Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

globenewswire.com · 8 Jul 2026

Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel.

Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

prnewswire.com · 8 Jul 2026

Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. MOGADORE, Ohio and VANCOUVER, BC, July 8, 2026 /PRNewswire/ -- Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix") (CSE: BLO) (OTCID: BLOZF) announce the development and validation of a DOT-like drug-test panel for breath testing.

Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath

globenewswire.com · 2 Jul 2026

Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath

Methamphetamine & Amphetamine Detection in Breath Represents a Significant New Opportunity for Cannabix Technologies Inc. Methamphetamine & Amphetamine Detection in Breath Represents a Significant New Opportunity for Cannabix Technologies Inc.

Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector

globenewswire.com · 29 Jun 2026

Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector

VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices, is pleased to announce its first deployment of BreathLogix alcohol screening devices in Africa, through a West African distributor specializing in industrial safety solutions for mining clients. The delivery is being coordinated through Montreal based Alco Prevention Canada.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.